Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia

Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine

Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy

Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?

A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia

Anti-cancer vaccine therapy for hematologic malignancies: An evolving era

Efficacy of intracellular immune checkpoint-silenced DC vaccine

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Recent developments in immunotherapy of acute myeloid leukemia